Therapeutic problems in type II diabetic patients developing insulin requirement

Journal of Diabetes and its Complications

Volumn 10, Issue 5, 1996, Pages 255-260

  Leutenegger, M ^a   Bertin, E ^a   Grulet, H ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; DIET RESTRICTION; DRUG COMBINATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN INFUSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; LOW CALORY DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW;

EID: 0030578872     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(96)00043-8     Document Type: Article

References (31)

1. 1. Groop L, Schalin C, Franssila-Kallundi A, Widen E, Ekstrand A, Eriksson J: Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. Am J Med 87:183-190, 1987.
2. 2. Leutenegger M, Gross A, Osterman G, Grulet H, Pasqual C, Dijoux B: Le diabète insulinorequérant. Diabete Métab 14:463-470, 1988.
3. 3. Unger RH, Grundy S: Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance. Diabetologia 28:121, 1988.
4. 4. Yki-Järvinen H: Glucose toxicity. Endocr Rev 415-431, 1992.
5. 5. Galloway JA: Treatment of NIDDM with insulin agonists of substitutes. Diabetes Care 13:1209-1239, 1990.
6. 6. Genuth S: Management of the adult onset diabetic with sulfonylurea drug failure. Endocrinol Metab Clin North Am 21:351-371, 1992.
7. 7. Taskinen MR, Kuusi T, Helve E, Nikkala EA, Yky-Järvinen H: Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes. Arteriosclerosis 8:168-177, 1988.
8. 8. Hughes TA, Clements RS, Fairclough PK, Bell DSH, Segrest JP: Effect of insulin therapy on lipoproteins in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis 67:105-114, 1987.
9. 9. Garvey WT, Olefsky JM, Griffin J, Hamman RF, Kolterman OG: The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222-234, 1985.
10. 10. Eastman, Gorden P: The DCCT: Implications for diabetes treatment. Diabetes Rev 2:263-271,1994.
11. 11. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes II mortality results. Diabetes 19 (suppl 2): 789-830, 1970.
12. 12. Turner, RC: Principes de l'étude prospective sur le diabète au Royaume-Uni, in: Journées de Diabétologie de l'Hôtel-Dieu, Flammarion Ed. Paris, 1994, pp. 101-103.
13. 13. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS: Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care 16:21-31, 1993.
14. 14. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1495-1607, 1988.
15. 15. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease. Diabetologia 37:948-952, 1994.
16. 16. Chiasson JL, Losse RG, Hunt JA: The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 121:928-935, 1994.
17. 17. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl J Med 331:1188-1193, 1994.
18. 18. Gutniak MK, Linde B, Holst JJ, Efendie S: Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care 17:1039-1044, 1994.
19. 19. Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH: Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 151:1334-1340, 1991.
20. 20. Mirouze J, Augustin-Pascalis I: Secondary failure of oral antidiabetic and dietetic therapy in non-insulin-dependent diabetes mellitus - Remission through short sessions of continuous intravenous insulin infusion. Diabetes Res Clin Pract 4 (suppl 1):41, 1988.
21. 21. Grulet H, Gross A, Pasqual H, Durlach V, Leutenegger M. Remission of insulin requirement in late secondary failure to oral hypoglycemic agents (IRD): Results at 24 months and analysis of predictive factors. Diabetes Res Clin Pract 13:189-198, 1991.
22. 22. Leutenegger M, Nakib Y, Grulet H, Gross A, Boirie Y: Les échecs retardés des traitements antidiabétiques oraux. Place de l'association insuline-sulfamides hypoglycémiants. in: Journées de Diabétologie Hôtel-Dieu, Flammarion Ed. Paris, 1993, pp. 97-114.
23. 23. Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppala P, Tulokas T, Viikari J, Karjalainen J, Taskinen MR: Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327:1426-1433, 1992.
24. 24. Landstedt-Hallin L, Adamson U, Arner P, Bolinder J, Lins PE: Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure. Diabetes Care 18:1183-1186, 1995.
25. 25. Peters AL, Davidson MB: Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med 115:45-53, 1991.
26. 26. Halimi S, Corticelli P, Benhamou PY; combination of insulin and sulfonylureas: A literature review. Am J Med 90 (Suppl 6A):83S-86S, 1991.
27. 27. Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ: Is combination sulfonylurea and insulin therapy useful in NIDDM patient? Diabetes Care 15:953-959, 1992.
28. 28. Leblanc H, Marre M, Billault B,
29. 29. Grulet H., Durlach V, Hécart AC, Gross A, Leutenegger M: Study of the rate of early glucose disappearance following insulin injection: Insulin sensitivity index. Diabetes Res Clin Pract 20:201-207, 1993.
30. 30. Hoster JP, Matthews DR, Rudenski AS, Burnet MA, Darling P, Bown EG, Turner RC. Continuous infusion of glucose with model assessment: Measurement of insulin resistance and β cell function in man. Diabetologia 28:401-411, 1985.
31. 31. Alberti KGMM, Gries FA: Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diabetic Med 5:275-281, 1988.s